🔗 Share this article

This year's prestigious award in Physiology or Medicine was awarded for transformative discoveries that clarify how the body's defense network attacks harmful pathogens while sparing the body's own cells.

Three esteemed scientists—from Japan Shimon Sakaguchi and American experts Mary Brunkow and Dr. Ramsdell—received this accolade.

The work identified unique "sentinels" within the immune system that remove rogue immune cells that could harming the organism.

The discoveries are now paving the way for innovative therapies for autoimmune diseases and malignancies.

These winners will divide a prize fund worth 11m SEK.

Decisive Findings

"Their research has been essential for comprehending how the body's defenses functions and why we do not all suffer from serious self-attack conditions," commented the chair of the award panel.

This team's research explain a core mystery: How does the immune system defend us from countless infections while keeping our own tissues unharmed?

The body's protection system uses immune cells that scan for indicators of infection, including pathogens and germs it has not met before.

These defenders employ detectors—known as recognition units—that are generated randomly in countless variations.

That gives the immune system the ability to fight a wide array of invaders, but the randomness of the mechanism unavoidably creates immune cells that can attack the body.

Protectors of the Immune System

Researchers previously knew that a portion of these harmful white blood cells were eliminated in the immune organ—the site where immune cells mature.

This year's award recognizes the discovery of T-reg cells—described as the immune system's "peacekeepers"—which travel through the system to disarm other immune cells that attack the body's own tissues.

We know that this mechanism fails in autoimmune diseases such as juvenile diabetes, multiple sclerosis, and rheumatoid arthritis.

The prize committee stated, "The findings have established a new field of research and spurred the development of new treatments, for instance for tumors and autoimmune diseases."

In malignancies, T-regs block the body from attacking the growth, so research are focused on reducing their quantity.

For autoimmune diseases, trials are exploring increasing regulatory T-cells so the body is not under attack. A comparable method could also be useful in minimizing the risks of transplanted organ failure.

Pioneering Studies

Professor Sakaguchi, from Osaka University, performed experiments on rodents that had their immune gland removed, leading to autoimmune disease.

He showed that injecting immune cells from other mice could prevent the disease—implying there was a system for blocking immune cells from attacking the host.

Dr. Brunkow, affiliated with the a research center in a US city, and Fred Ramsdell, currently at a biotech firm in San Francisco, were studying an inherited autoimmune disease in mice and people that resulted in the identification of a genetic factor critical for the way regulatory T-cells operate.

"Their groundbreaking research has revealed how the immune system is controlled by regulatory T cells, preventing it from accidentally attacking the healthy cells," commented a prominent biological science expert.

"The research is a striking example of how basic biological study can have far-reaching consequences for human health."